This report describes the accuracy of new biomarkers CSF T-Tf (WB) including its two isoforms Tf-1 and Tf-β2 in identifying CJD+ from dementia of other causes. This evidence concerns the gene GTF2H4 and Creutzfeldt Jacob disease.